Overview

Ablepharon-macrostomia syndrome (AMS) is a rare genetic disorder characterised by a combination of physical malformations, including underdeveloped or absent eyelids (ablepharon), wide mouth (macrostomia), and a range of other anomalies. AMS is part of a broader spectrum of ectodermal dysplasia syndromes that affect the development of the skin, hair, nails, teeth, and sweat glands.¹ 

According to research, other observed characteristics include poorly developed cheeks (malar hypoplasia), absent or extremely small (hypoplastic) nipples, abnormalities of the umbilical region, and growth retardation.²

This article delves into the treatment and management strategies for AMS, addressing surgical interventions and supportive care measures essential for improving the quality of life for affected individuals.

Clinical features and diagnosis

AMS presents a distinct set of clinical features that aid in its diagnosis. In addition to ablepharon and macrostomia, patients may exhibit other facial dysmorphisms, such as low-set ears, absent or sparse eyebrows and eyelashes, and malformed auricles. There have also been cases that identified underdeveloped pinnae, low-set ears with collapsed ear canals and hearing loss, a small nose with triangular nostrils, thin lips, and excessive skin folds.³ 

Systemic anomalies can include skin abnormalities, genital malformations, and occasionally developmental delays or intellectual disabilities. Genetic testing often reveals mutations in the TWIST2 gene, which plays a crucial role in craniofacial development.⁴

Surgical treatment

Eyelid reconstruction

One of the most critical aspects of treating AMS is the surgical reconstruction of the eyelids. The absence or severe underdevelopment of eyelids can lead to exposure keratopathy, corneal ulcers, and subsequent vision loss. Therefore, early intervention is paramount.⁵

Eyelid reconstruction techniques

Local flaps

The use of local flaps, such as the Cutler-Beard procedure, involves transferring adjacent skin and muscles to form new eyelids. This method is often the first line of treatment, aiming to provide immediate protection to the cornea.⁶

Skin grafts 

In cases where local flaps are insufficient, full-thickness skin grafts from other body parts can be employed. The grafted skin is carefully matched to the delicate skin of the periocular area to ensure both functionality and cosmetic appearance.^6,7

Tarsoconjunctival grafts

These grafts are used to reconstruct the inner lining of the eyelids, providing stability and preventing inward turning of the eyelashes (trichiasis) which can damage the cornea.³

Mouth and facial reconstruction

Macrostomia correction is another vital surgical intervention. The aim is to achieve a more normal oral aperture (mouth opening) size and improve both function and aesthetics.⁸

Macrostomia correction techniques

1. Z-Plasty

This technique involves creating Z-shaped incisions around the corners of the mouth to realign the tissue and reduce the size of the oral opening while minimising scar contraction.^8,9 

Z-plasty is commonly used for skin closure for muscle damage and provides satisfactory scars and outcomes.¹⁰

2. Wedge excision

It involves excising a wedge-shaped segment of tissue from the corners of the mouth, followed by meticulous suturing to narrow the oral aperture. Adequate repair of the muscle around the mouth is consistently emphasised as the key component of successful macrostomia correction.^9,10

3. Muscle repositioning 

Repositioning and suturing the orbicularis oris muscle, which encircles the mouth, helps in achieving both functional competence and aesthetic balance.^8,9,10

Multidisciplinary support and management

Ophthalmological care

Continuous ophthalmological care is essential for patients with AMS. Post-surgical follow-up ensures that the reconstructed eyelids function properly and protect the eyes. Regular monitoring for any signs of corneal damage or dryness is critical. Lubricating eye drops and ointments are often prescribed to maintain corneal hydration.^11,12

Dermatological and dental care

Given the skin anomalies associated with AMS, dermatological care focuses on managing dryness, preventing infections, and addressing any skin lesions.¹¹ 

Regular dental evaluations are also crucial due to common dental anomalies such as hypodontia (missing teeth) and malformed teeth, which may require orthodontic treatments or prosthetic replacements.¹²

Psychological and developmental support

Psychological support plays a significant role in the holistic management of AMS. The visible physical differences can impact the self-esteem and social interactions of affected individuals. Early engagement with mental health professionals, including psychologists and social workers, helps provide coping strategies and support to the patients and their families.^11,12

Genetic counselling

Genetic counselling is an integral part of the management of AMS. Since AMS can be inherited in an autosomal dominant pattern, families need to understand the genetic implications, recurrence risks, and the possibility of prenatal diagnosis in future pregnancies. Genetic counsellors provide information and support, helping families make informed decisions about their reproductive options.²⁰

Advances in research and future directions

Recent advancements in genetic research have provided deeper insights into the molecular mechanisms underlying AMS. Studies focusing on the TWIST2 gene and its role in craniofacial development are paving the way for potential gene therapy approaches. Although still in experimental stages, gene therapy holds promise for correcting the underlying genetic defects in AMS, offering hope for more definitive treatments in the future.

Additionally, tissue engineering and regenerative medicine are emerging fields that may revolutionize the surgical treatment of AMS. Techniques such as 3D bioprinting of tissues and organs could provide more tailored and effective reconstructive options, minimising the need for multiple surgeries and improving outcomes. 

Applying these techniques to AMS might offer more personalized and effective reconstructive options, potentially reducing the necessity for multiple surgeries and enhancing outcomes. However, it is important to note that using these advanced methods for AMS treatment remains speculative and demands substantial research and clinical trials before it can be realised.¹³

Challenges and considerations

Surgical complications

Surgical interventions in AMS carry the risk of complications, including infection, scarring, and graft failure. Meticulous surgical planning and postoperative care are essential to minimise these risks. Surgeons must balance the functional and aesthetic outcomes while addressing the complex anatomical anomalies in AMS patients.¹⁴

Long-term management

The chronic nature of AMS necessitates long-term management strategies. Regular follow-ups with a multidisciplinary team ensure that any emerging issues are promptly addressed. Lifelong monitoring of ocular health, skin condition, and dental status is crucial to maintaining the quality of life for AMS patients.^14,15

FAQs

When is the best time to perform surgical interventions for AMS?

The timing of surgical interventions in AMS can be crucial. For eyelid abnormalities, early intervention is often necessary to protect the cornea and preserve vision. Some surgeons recommend initial procedures in infancy, with potential follow-up surgeries later in life. For other features like macrostomia, the timing may depend on the severity of the condition and its impact on the child's development. It's important to balance the need for functional improvement with considerations of growth and development.^16,18

Are there any non-surgical treatments for AMS?

While surgical interventions are central to AMS management, several non-surgical treatments are also important:^16,18

• Lubricating eye drops and ointments to protect the cornea in cases of incomplete eyelid closure
• Skin care regimens to manage dermatological issues
• Speech therapy may be beneficial for patients with oral abnormalities
• Physical and occupational therapy can help address any motor skill delays

What are the long-term outcomes for individuals with AMS?

With appropriate management, many individuals with AMS can achieve significant improvements in functionality and quality of life. However, outcomes can vary depending on the severity of the condition and the effectiveness of treatments. Long-term follow-up of patients who underwent eyelid reconstruction shows that corneal health can be maintained with appropriate surgical techniques. However, some degree of visual impairment may persist in some cases. Psychosocial outcomes can be positively influenced by comprehensive care that includes psychological support and interventions to improve appearance and function.^17,18

Are there any ongoing research or clinical trials for AMS?

Research into AMS is ongoing, particularly in genetics and potential targeted therapies. Identifying mutations in the TWIST2 gene as the cause of AMS has opened up new avenues for research. While there are currently no specific clinical trials for AMS treatments, advances in fields such as gene therapy and tissue engineering may hold promise for future therapies. Patients and families are encouraged to stay informed about research developments through rare disease organisations and their healthcare providers.¹⁷

How is genetic counselling approached for AMS?

Genetic counselling for AMS typically involves:

• Explaining the autosomal dominant inheritance pattern of AMS²⁰
• Discussing the role of the TWIST2 gene and the possibility of genetic testing
• Addressing the risk of recurrence in future pregnancies
• Providing information about prenatal testing options
• Offering support and resources for families affected by AMS

It's important to note that most cases of AMS occur sporadically due to new mutations, but genetic counselling is still valuable for understanding the condition and its implications.^17,18,19

What is the main focus of treatment for AMS?

The main focus is protecting and preserving the eyes, particularly the cornea. This is crucial because AMS can cause severe eye problems due to underdeveloped eyelids.^16,17,21

Summary

The treatment and management of Ablepharon-Macrostomia syndrome require a comprehensive and multidisciplinary approach. Surgical interventions, particularly eyelid and mouth reconstructions, play a pivotal role in addressing the primary anomalies. However, supportive care involving ophthalmological, dermatological, dental, psychological, and genetic counselling is equally crucial in ensuring holistic care for affected individuals. Genetic research and tissue engineering advances hold promise for future therapies that may offer more definitive solutions. Despite the challenges, with meticulous care and innovative treatments, individuals with AMS can achieve improved functionality and quality of life.